The SRSF8 antibody is a tool used to detect and study the Serine/arginine-rich splicing factor 8 (SRSF8), a member of the SR protein family involved in pre-mRNA splicing. SR proteins are essential for constitutive and alternative splicing, regulating gene expression by binding to RNA motifs and mediating spliceosome assembly. SRSF8. also known as SRp46. contains an RNA recognition motif (RRM) and a C-terminal arginine/serine-rich (RS) domain, enabling interactions with other splicing factors and RNA. It plays roles in splice site selection, mRNA export, and translation regulation. Dysregulation of SRSF8 has been linked to diseases, including cancer, where aberrant splicing contributes to tumor progression. The SRSF8 antibody is widely used in research to investigate its expression, localization (primarily nuclear), and function in cellular processes like proliferation, apoptosis, and stress responses. It is validated in techniques such as Western blotting, immunofluorescence, and immunoprecipitation, aiding studies on splicing mechanisms and disease pathways. Commercial SRSF8 antibodies are typically raised in rabbits or mice, with specificity confirmed via knockout/knockdown controls. Understanding SRSF8's role through antibody-based assays provides insights into RNA metabolism and potential therapeutic targets.